Seer Inc. Cl A (SEER): Price and Financial Metrics

Seer Inc. Cl A (SEER): $6.13

0.06 (+0.99%)

POWR Rating

Component Grades













Add SEER to Watchlist
Sign Up

Industry: Biotech



in industry


  • SEER scores best on the Value dimension, with a Value rank ahead of 34.17% of US stocks.
  • SEER's strongest trending metric is Growth; it's been moving down over the last 179 days.
  • SEER's current lowest rank is in the Quality metric (where it is better than 4.75% of US stocks).

SEER Stock Summary

  • SEER's price/sales ratio is 27.25; that's higher than the P/S ratio of 95.33% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.09 for SEER INC; that's greater than it is for merely 7.84% of US stocks.
  • Revenue growth over the past 12 months for SEER INC comes in at 258.99%, a number that bests 96.55% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SEER INC are IONQ, RKLB, HOOD, AI, and QNST.
  • Visit SEER's SEC page to see the company's official filings. To visit the company's web site, go to

SEER Valuation Summary

  • In comparison to the median Healthcare stock, SEER's price/sales ratio is 1350% higher, now standing at 29.
  • SEER's price/earnings ratio has moved up 127.6 over the prior 24 months.

Below are key valuation metrics over time for SEER.

Stock Date P/S P/B P/E EV/EBIT
SEER 2022-11-25 29.0 0.9 -4.5 -4.1
SEER 2022-11-23 27.7 0.8 -4.3 -3.9
SEER 2022-11-22 27.5 0.8 -4.3 -3.8
SEER 2022-11-21 27.7 0.8 -4.3 -3.8
SEER 2022-11-18 29.4 0.9 -4.6 -4.1
SEER 2022-11-17 31.4 1.0 -4.9 -4.4

SEER Price Target

For more insight on analysts targets of SEER, see our SEER price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.00 Average Broker Recommendation 1.75 (Moderate Buy)

SEER Stock Price Chart Interactive Chart >

Price chart for SEER

SEER Price/Volume Stats

Current price $6.13 52-week high $27.84
Prev. close $6.07 52-week low $5.83
Day low $5.96 Volume 292,100
Day high $6.32 Avg. volume 361,903
50-day MA $7.27 Dividend yield N/A
200-day MA $9.68 Market Cap 384.00M

Seer Inc. Cl A (SEER) Company Bio

Seer, Inc., a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. The company develops Proteograph, an integrated solution comprising consumables, automation instrumentation, and proprietary software that performs proteomics analysis. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

SEER Latest News Stream

Event/Time News Detail
Loading, please wait...

SEER Latest Social Stream

Loading social stream, please wait...

View Full SEER Social Stream

Latest SEER News From Around the Web

Below are the latest news stories about SEER INC that investors may wish to consider to help them evaluate SEER as an investment opportunity.

Analysts Just Made A Major Revision To Their Seer, Inc. (NASDAQ:SEER) Revenue Forecasts

One thing we could say about the analysts on Seer, Inc. ( NASDAQ:SEER ) - they aren't optimistic, having just made a...

Yahoo | November 16, 2022

Seer (SEER) Gets a Hold from Morgan Stanley

In a report released today, Tejas Savant from Morgan Stanley maintained a Hold rating on Seer (SEER - Research Report), with a price target of $11.00. The company's shares opened today at $7.16.Savant covers the Healthcare sector, focusing on stocks such as Hologic, Illumina, and Thermo Fisher. According to TipRanks, Savant has an average return of -14.9% and a 28.41% success rate on recommended stocks. Seer has an analyst consensus of Hold, with a price target consensus of $10.00, implying a 39.66% upside from current levels. In a report released yesterday, J.P. Morgan also maintained a Hold rating on the stock with a $10.00 price target.

Catie Powers on TipRanks | November 10, 2022

Investing in Seer Inc. (SEER) might be an excellent idea, but the stock is currently overvalued/undervalued

A share of Seer Inc. (NASDAQ:SEER) closed at $6.79 per share on Wednesday, up from $6.43 day before. While Seer Inc. has overperformed by 5.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SEER fell by -80.74%, with highs and lows ranging from $36.52 to $5.96, […]

US Post News | November 10, 2022

Seer Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

Seer ( NASDAQ:SEER ) Third Quarter 2022 Results Key Financial Results Revenue: US$3.96m (up 84% from 3Q 2021). Net...

Yahoo | November 10, 2022

Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates

Seer, Inc. (SEER) delivered earnings and revenue surprises of 0% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 9, 2022

Read More 'SEER' Stories Here

SEER Price Returns

1-mo -21.71%
3-mo -38.14%
6-mo -32.04%
1-year -72.52%
3-year N/A
5-year N/A
YTD -73.13%
2021 -59.37%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7525 seconds.